VIRBAC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 358 EUR | +1.13% |
|
-0.56% | -0.42% |
| May. 03 | VIRBAC : Virbac remains an attractive animal healthcare play |  |
| Apr. 17 | VIRBAC : A healthy start to 2024; outlook re-iterated | |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Veterinary Drugs
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 3.25B | ||||||
| 77.37B | ||||||
| 8.74B | - | |||||
| 3.67B | ||||||
| 1.73B | ||||||
| 1.38B |
- Stock Market
- Equities
- VIRP Stock
- Charts Virbac
- Sector Chart
